Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Background. A self-medication hypothesis has been proposed to explain the association between cannabis use and psychiatric and behavioral problems. However, little is known about the reasons for use and reactions while intoxicated in cannabis users who suffer from depression or problems controlling violent behavior. Method. We assessed 119 cannabis-dependent subjects using the Schedules of Clinical Assessment in Neuropsychiatry (SCAN), parts of the Addiction Severity Index (ASI), and questionnaires on reasons for cannabis use and reactions to cannabis use while intoxicated. Participants with lifetime depression and problems controlling violent behavior were compared to subjects without such problems. Validity of the groupings was corroborated by use of a psychiatric treatment register, previous use of psychotropic medication and convictions for violence. Results. Subjects with lifetime depression used cannabis for the same reasons as others. While under the influence of cannabis, they more often experienced depression, sadness, anxiety and paranoia, and they were less likely to report happiness or euphoria. Participants reporting problems controlling violent behavior more often used cannabis to decrease aggression, decrease suspiciousness, and for relaxation; while intoxicated they more often reacted with aggression. Conclusions. Subjects with prior depression do not use cannabis as a mean of self-medication. They are more likely to experience specific increases of adverse symptoms while under the influence of cannabis, and are less likely to experience specific symptom relief. There is some evidence that cannabis is used as a means of self-medication for problems controlling aggression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1259 · Cited by 2,538
SCAN: Schedules fonr Clinical Assessment in Neuropsychiatry
Wing, J. K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810180089012 · Cited by 2,517
Cannabis use and mental health in young people: cohort study.
Patton, G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., & Hall, W. (2002) · BMJ · doi:10.1136/bmj.325.7374.1195 · Cited by 997 · cited 4×
“2004), as well as daily cannabis users from the general population (Patton et al. 2002).”
BackgroundResultInfluentialConway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0211 · Cited by 934 · cited 1×
“Epidemiological studies have also shown an association between cannabis use disorders and affective disorders (e.g. Conway et al. 2006).”
BackgroundMacleod, J., Oakes, R., Copello, A., Crome, I., Egger, M., Hickman, M., Oppenkowski, T., Stokes-Lampard, H., & Smith, G. D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16200-4 · Cited by 639 · cited 2×
“…use, and (3) third factor models, where bias in study design or confounding factors, such as low socio-economic status, other drug use, personality and involvement with drug-using peers, explain the association rather than cannabis per se (Johns, 2001; Arseneault et al. 2004; Macleod et al. 2004).”
BackgroundCannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
Tramèr, M. R., Carroll, D., Campbell, F. A., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001) · BMJ · doi:10.1136/bmj.323.7303.16 · Cited by 610 · cited 1×
“…Atha & Blanchard, 1997; Gruber et al. 1997; Lyons et al. 1997; Reilly et al. 1998), in patients suffering from schizophrenia (Knudsen & Vilmar, 1984; Negrete et al. 1986; Dixon et al. 1991; Warner et al. 1994; Addington & Duchak, 1997) and in placebo-controlled medical trials (Tramer et al. 2001).”
BackgroundExploring the association between cannabis use and depression.
Degenhardt, L., Hall, W., & Lynskey, M. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00437.x · Cited by 587 · cited 6×
“…that antidepressant effects are specifically sought by cannabis users or that cannabis specifically relieves these problems (Degenhardt et al. 2003), or that the risk of cannabis use is higher after the onset of depressive episodes (Bovasso, 2001; Patton et al. 2002; Degenhardt et al. 2003).”
BackgroundResultInfluentialDrug abuse in schizophrenic patients: clinical correlates and reasons for use
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.2.224 · Cited by 547 · cited 6×
“Some studies have shown that many use the substance to alleviate depressive symptoms (Dixon et al. 1990, 1991; Warner et al. 1994; Gruber et al. 1996, 1997; Ogborne et al. 2000).”
BackgroundMethodInfluentialDrug treatment outcomes for adolescents with comorbid mental and substance use disorders
GRELLA, C. E., HSER, Y.-I., JOSHI, V., & ROUNDS-BRYANT, J. (2001) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200106000-00006 · Cited by 379
Budney, A. J., Higgins, S. T., Radonovich, K. J., & Novy, P. L. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.6.1051 · Cited by 318
Cannabis use predicts future psychotic symptoms, and vice versa
Ferdinand, R. F., Sondeijker, F., Van Der Ende, J., Selten, J., Huizink, A., & Verhulst, F. C. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01070.x · Cited by 212 · cited 1×
“Some studies have found tentative evidence (Knudsen & Vilmar, 1984; Schneier & Siris, 1987; Dixon et al. 1990, 1991; Warner et al. 1994; Addington & Duchak, 1997; Ferdinand et al. 2005).”
BackgroundThe Marijuana Treatment Project: rationale, design and participant characteristics
Stephens, R. S., Babor, T. F., Kadden, R., Miller, M., & The Marijuana Treatment Project Research Group (2002) · Addiction · doi:10.1046/j.1360-0443.97.s01.6.x · Cited by 178
Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment
Tims, F. M., Dennis, M. L., Hamilton, N., J. Buchan, B., Diamond, G., Funk, R., & Brantley, L. B. (2002) · Addiction · doi:10.1046/j.1360-0443.97.s01.7.x · Cited by 140
Urbanoski, K. A., Strike, C. J., & Rush, B. R. (2005) · European Addiction Research · doi:10.1159/000085546 · Cited by 41 · cited 1×
“However, the subjects did display a rate of co-morbid substance use similar to that reported in other studies on cannabis users in substance abuse treatment (e.g. Stephens et al. 1993; Copeland et al. 2001; Urbanoski et al. 2005).”
Result
Cited by
Cannabis and anxiety: a critical review of the evidence
Crippa, J. A., Zuardi, A. W., Martín‐Santos, R., Bhattacharyya, S., Atakan, Z., McGuire, P., & Fusar‐Poli, P. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1048 · Cited by 509
Bolton, J. M., Robinson, J., & Sareen, J. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.003 · Cited by 448
Cannabis, the mind and society: the hash realities
Murray, R. M., Morrison, P. D., Henquet, C., & Forti, M. D. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2253 · Cited by 322
Wilkinson, S. T., Stefanovics, E., & Rosenheck, R. A. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09475 · Cited by 145
Aragona, M., Onesti, E., Tomassini, V., Conte, A., Gupta, S., Gilio, F., Pantano, P., Pozzilli, C., & Inghilleri, M. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181633497 · Cited by 109
Metadata
- Authors
- ARENDT, M., ROSENBERG, R., FJORDBACK, L., BRANDHOLDT, J., FOLDAGER, L., SHER, L., & MUNK-JØRGENSEN, P.
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2007-01-04
- Volume
- 37
- Issue
- 7
- Pages
- 935-945
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2114883226
- Cited by
- 124
- References
- 14
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.